GF
FOLD

Gabelli Funds’s Amicus Therapeutics FOLD Stock Holding History

Gabelli Funds’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-942,650
Closed -$13.6M – 1315
2026
Q1 		$13.6M Buy
942,650
+389,700
+70% +$5.59M 0.09% 264
2025
Q4 		$7.87M Buy
+552,950
New +$5.43M 0.05% 374

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Gabelli Funds's FOLD Position: Q2 2026 in Review

Gabelli Funds sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 942,650 shares — an estimated $13.6M sold.

Gabelli Funds first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $13.6M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Gabelli Funds reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Gabelli Funds sold 942,650 Amicus Therapeutics shares in Q2 2026, an estimated $13.6M.
  • Gabelli Funds first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Gabelli Funds's Amicus Therapeutics position peaked at $13.6M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.